Bellerophon Therapeutics, Inc. BLPH
0.01 0.00 0.00%
As of Dec 18, 12:51 PM ET
52-week range unavailable
- Open
- 0.0126
- Prev close
- 0.012
- Mkt cap
- 146.79K
- Vol
- 1.56K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.012
- High
- 0.0126
- Forward P/E
- -0.45
- Beta
- 0.60
- Short ratio
- 0.39
- Inst. own
- 44.43%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 17, 2024
- 50-d avg
- 4.34
- 200-d avg
- 3.45
- 1y target
- 2.00
5D chart
Chart tools
Chart is warming up
The five-day price history for BLPH has not been loaded yet. Try again in a moment.
Altman Z-Score
-77.28 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.4×
P/S 0.0×
P/B 3.4×
P/FCF -0.5×
EV/EBITDA -0.1×
EV/Sales 0.0×
FCF Yield -206.7%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -782.6%
ROIC -729.0%
ROA -249.9%
Revenue 0.0%
Operating Income -11.0%
EPS (diluted) -11.2%
Free Cash Flow 22.1%
Current Ratio 1.4×
Quick Ratio 1.4×
Debt / Equity 0.1×
Net Debt / EBITDA 0.3×
Interest Coverage -166×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31